Literature DB >> 11140868

Pathologic analysis of the sentinel lymph node.

P A Treseler1, P S Tauchi.   

Abstract

The development of the sentinel lymph node concept has had a revolutionary effect on the way radical cancer surgery is viewed. The selective excision of the sentinel node alone has been proposed as an alternative to complete regional lymphadenectomy. This article addresses the sentinel lymph node hypothesis and the role of pathologic analysis, radiation safety, intraoperative and postoperative assessment, pathologic analysis in prognosis, and polymerase chain reaction-based studies.

Entities:  

Mesh:

Year:  2000        PMID: 11140868     DOI: 10.1016/s0039-6109(05)70256-5

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  4 in total

1.  Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up.

Authors:  Stanley P L Leong; Mohammed Kashani-Sabet; Renee A Desmond; Robert P Kim; Dennis H Nguyen; Kensho Iwanaga; Patrick A Treseler; Robert E Allen; Eugene T Morita; Yuting Zhang; Richard W Sagebiel; Seng-Jaw Soong
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

2.  Histopathological patterns of melanoma metastases in sentinel lymph nodes.

Authors:  C A Murray; W L Leong; D R McCready; D M Ghazarian
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

Review 3.  Sentinel lymph node mapping and selective lymphadenectomy: the standard of care for melanoma.

Authors:  Stanley P L Leong
Journal:  Curr Treat Options Oncol       Date:  2004-06

4.  Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with 'MCW melanoma cocktail'--a mixture of monoclonal antibodies to MART-1, Melan-A, and tyrosinase.

Authors:  Vinod B Shidham; Dan Qi; R Nagarjun Rao; Scott M Acker; Chung-Che Chang; Bal Kampalath; Glen Dawson; Jinobya K Machhi; Richard A Komorowski
Journal:  BMC Cancer       Date:  2003-05-07       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.